Iron chelation with oral deferiprone in patients with thalassemia

N Engl J Med. 1998 Dec 3;339(23):1712; author reply 1713-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Deferiprone
  • Humans
  • Iron / analysis
  • Iron Chelating Agents / adverse effects
  • Iron Chelating Agents / therapeutic use*
  • Iron Overload / drug therapy*
  • Liver / chemistry
  • Liver Cirrhosis / etiology
  • Pyridones / adverse effects
  • Pyridones / therapeutic use*
  • beta-Thalassemia / drug therapy*

Substances

  • Iron Chelating Agents
  • Pyridones
  • Deferiprone
  • Iron